Bridgepoint-backed Swedish renal care provider Diaverum has announced plans to launch an initial public offering (IPO) on Nasdaq Stockholm.
Announcement follows a series of discussions with potential strategic and financial investors
Board of the UK-based listed pharmaceuticals company has agreed to the offer
Venture capital firm Felix Capital appoints Susan Lin and Julien Codorniou as its new partners
Private equity suitors could preempt the auction given the popularity of the space